ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs MXN
20.7185
0.00%
Brent Oil
79.285
0.00%
Bitcoin
94,106.56
-0.63%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Anebulo Pharmaceuticals Inc (ANEB) Cotización

Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc (ANEB)

NASDAQ
1.46
-0.17
(-10.43%)
Cerrado 11 Enero 3:00PM
Delayed by 15 minutes
1.46
0.00
(0.00%)
Fuera de horario: 4:16PM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
1.46
Postura de Compra
1.22
Postura de Venta
1.60
Volume Operado de la Acción
19,864
1.46 Rango del Día 1.6484
0.8001 Rango de 52 semanas 3.30
Capitalización de Mercado [m]
37.862M
Precio Anterior
1.63
Precio de Apertura
1.52
Hora
5
@
1.53
Última hora de negociación
Volumen financiero
US$ 30,559
Precio Promedio Ponderado
1.5384
Volumen promedio (3 m)
28,528
Acciones en circulación
25,933,217
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-4.62
Beneficio por acción (BPA)
-0.32
turnover
-
Beneficio neto
-8.2M

Acerca de Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.anebulo.com
Sede
Dover, Delaware, USA
Fundado
-
Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was US$1.63. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of US$ 0.8001 to US$ 3.30.

Anebulo Pharmaceuticals currently has 25,933,217 shares in issue. The market capitalisation of Anebulo Pharmaceuticals is US$42.27 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.62.

ANEB Últimas noticias

Más noticias

Form 8-K - Current report

23 Diciembre 2024
Edgar (US Regulatory)

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

23 Diciembre 2024
Business Wire

Form 8-K - Current report

13 Noviembre 2024
Edgar (US Regulatory)

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or...

13 Noviembre 2024
Business Wire

Form 8-K - Current report

17 Octubre 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

25 Septiembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

25 Septiembre 2024
Edgar (US Regulatory)

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

25 Septiembre 2024
Business Wire

Form 8-K - Current report

22 Julio 2024
Edgar (US Regulatory)

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

22 Julio 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0884-5.709119090671.54841.71.4688781.63689377CS
40.085.797101449281.381.80.8001803721.38065175CS
12-0.37-20.2185792351.8320.8001285281.40266557CS
26-1.05-41.83266932272.513.080.8001165381.59456169CS
52-1.05-41.83266932272.513.30.8001114481.87106821CS
156-5.17-77.97888386126.637.8850.8001102062.80241659CS
260-5.92-80.2168021687.389.330.8001111703.92670169CS

ANEB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Anebulo Pharmaceuticals?
El precio actual de las acciones de Anebulo Pharmaceuticals es US$ 1.46
¿Cuántas acciones de Anebulo Pharmaceuticals están en circulación?
Anebulo Pharmaceuticals tiene 25,933,217 acciones en circulación
¿Cuál es la capitalización de mercado de Anebulo Pharmaceuticals?
La capitalización de mercado de Anebulo Pharmaceuticals es USD 42.27M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals ha negociado en un rango de US$ 0.8001 a US$ 3.30 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Anebulo Pharmaceuticals?
El ratio precio/beneficio de Anebulo Pharmaceuticals es -4.62
¿Cuál es la moneda de reporte de Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Anebulo Pharmaceuticals?
El último beneficio anual de Anebulo Pharmaceuticals es USD -8.2M
¿Cuál es la dirección registrada de Anebulo Pharmaceuticals?
La dirección registrada de Anebulo Pharmaceuticals es 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904
¿Cuál es la dirección del sitio web de Anebulo Pharmaceuticals?
La dirección del sitio web de Anebulo Pharmaceuticals es www.anebulo.com
¿En qué sector industrial opera Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

Discusión

Ver feed completo
Vexari Vexari 2 minutos hace
FDA Mandates Nerve Damage Warnings for 2 RSV Vaccines

Respiratory syncytial virus (RSV) activity is currently deemed to be ‘very high’ in many parts of the United States, according to CDC.

By Naveen Athrappully
1/9/2025 Updated: 1/10/2025

The U.S.
PFE
vein vein 2 minutos hace
Are you actually turning positive woop ?? 
LWLG
misterfishman misterfishman 2 minutos hace
The gospel truth no doubt.
IGPK
Explosivo Explosivo 2 minutos hace
Imagine believing someone who posts here consistently but doesn’t have a position in this stock. Let’s just think about that logically. Doesn’t make sense, does it? Do you really think we all believe that? You’re basically admitting that you are a loser with no life if that’s the case. You may be a
HMBL
threewheeler threewheeler 3 minutos hace
American Industries
@americanmade_ai
#controlledby Flowback with Freedom Well Testing and American Industries trading under the ticker symbol $AZRH

Freedom Well Testing, a 5 year old oilfield services company, brings extensive expertise in providing Flowback and Producti
AZRH
Konaploinks Konaploinks 3 minutos hace
However, Craig-Hallum’s Richard Shannon, an analyst ranked in the top 1% of Wall Street stock pros, believes Huang’s statement is quite an exaggeration – albeit not surprising, considering the chip giant could face potential threats from this segment.
IONQ
WooptdooU WooptdooU 3 minutos hace
Sorry,tp, I will be betting against you on this one. The tech and material are near completion. More engineers on it will be a boom. Your weeks and months don't matter...that's penny trader stuff...make your bet...and good luck.
LWLG
threewheeler threewheeler 3 minutos hace
American Industries
@americanmade_ai
#controlledby Flowback with Freedom Well Testing and American Industries trading under the ticker symbol $AZRH

Freedom Well Testing, a 5 year old oilfield services company, brings extensive expertise in providing Flowback and Producti
AZRH
wiredawg wiredawg 4 minutos hace
Something to chew on over the weekend: Quantum Machines, Rigetti Computing, and Nvidia announced today the successful application of AI to automate the calibration of a quantum computer. With their AI-powered tools, Quantum Elements and Qruise, remotely automated the calibration of a 9-qubit Rigetti
DGX
aBeezlee aBeezlee 4 minutos hace
Do you guys think this could ever hit dimes without RS? Been here for awhile as a speculative play, due to Chaintrade.
SMCE
EmpressMonk25 EmpressMonk25 4 minutos hace
I haven't had the opportunity today to conduct further research, but there's a possibility (though not confirmed) that the individual depicted in the Morgan Stanley photograph might be Rodolfo Toledo. If anyone has the time, I would appreciate it if they could look into this further. Please note, th
HMBL
surfer44 surfer44 5 minutos hace
Can Howard Marks Predict a Bubble Twice? I'm Calling It: IT's A BUBBLE (January 2025)

https://youtu.be/R-sxLzHezGs
TenKay TenKay 5 minutos hace
Hide my hand? What hand? LOL. My interest is only served by facts, I have no position in this stock long or short. He, on the other hand has a vested interest in only seeing the good side of things. It’s called confirmation bias.

And it has NOT served many a penny stock investor we
HMBL
threewheeler threewheeler 6 minutos hace
American Industries
@americanmade_ai
#controlledby Flowback with Freedom Well Testing and American Industries trading under the ticker symbol $AZRH

Freedom Well Testing, a 5 year old oilfield services company, brings extensive expertise in providing Flowback and Producti
AZRH
KILLAZILLA KILLAZILLA 6 minutos hace
The ambers aren't out yet and this POS SCAM trying to promote a FAKE product???

VERY BAD TASTE!!!
XERI
Stevenvegas Stevenvegas 7 minutos hace
watching this as well. I do see NAS issue resolved for now by Jan 7 PR. These bio plays are always lottery. Orphan drug status is interesting.
RNAZ
BottomBounce BottomBounce 7 minutos hace
Gold price flirts with multi-week top despite bullish USD; seems poised to climb further
https://www.fxstreet.com/news/gold-price-moves-away-from-four-week-peak-bears-seem-non-committed-202501090430
biosectinvestor biosectinvestor 8 minutos hace
I'm still up. Sorry, not losing mon this one... Many of us invested between .17 and .19.
NWBO
BottomBounce BottomBounce 8 minutos hace
Gold is poised for a new bullish phase, according to the charts. Here are the levels to watch
https://www.cnbc.com/2025/01/09/gold-is-poised-for-a-new-bullish-phase-according-to-the-charts-here-are-the-levels-to-watch.html
BottomBounce BottomBounce 8 minutos hace
Gold is poised for a new bullish phase, according to the charts. Here are the levels to watch
https://www.cnbc.com/2025/01/09/gold-is-poised-for-a-new-bullish-phase-according-to-the-charts-here-are-the-levels-to-watch.html
Huggy Bear Huggy Bear 8 minutos hace
You've held this scam all the way down?

Explains everything.
HMBL
DesertDrifter DesertDrifter 8 minutos hace
The loss of 45 million acres of boreal forest due to extreme drought a couple years ago will probably take centuries to recover, as they are not as adapted to disturbance as the temperate forests. People are just not designed for overloads of particulate matter for extended periods. Even caves we
BottomBounce BottomBounce 9 minutos hace
Gold Investors Stay Bullish for 2025 on Trump Volatility
https://finance.yahoo.com/news/gold-investors-stay-bullish-2025-050000881.html
Shawonsarker84 Shawonsarker84 9 minutos hace
I agree with TenKay. There is no real source to back this up.
HMBL

Su Consulta Reciente

NASDAQ
ANEB
Anebulo Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados